|
DESCRIPTION
AUROVISC is a viscoelastic solution of high molecular weight, highly
purified grade of hydroxypropyl methylcellulose 2%, clear, isotonic, sterile, non inflammatory and non-pyrogenic
in nature. It is used for intraocular injection during anterior segment surgery of the eye.
PROPERTIES
Molecular Weight : 86,000 daltons
Dynamic Viscosity : 3000 – 4500 cPs at 270C
pH : 6.0 – 7.8
CHARACTERISTICS
AUROVISC is a medical device used in the anterior segment surgery of the eye. It has the following unique characteristics:
- It maintains the depth of the anterior chamber of the eye and protects the periocular
tissues.
- Outstanding rheological properties.
- Completely transparent.
- Totally non antigenic.
- Simple to remove from the anterior chamber.
- Does not contain any proteins likely to cause inflammatory reactions and /or foreign
body reactions.
- Does not require refrigeration or not be stored at temperatures above 35 0C.
- Does not interfere with the process of Cicatrisation.
INDICATIONS
AUROVISC is indicated as a surgical aid (medical device) during surgical procedures
involving the anterior chamber of the eye, including extraction of the lens and insertion of
intraocular lenses. It maintains the depth of the anterior chamber during the whole
surgical procedure and permits greater operative precision without the risk of damaging
the endothelium of the cornea or other intraocular tissues.
PRECAUTIONS
Overfilling the anterior chamber of the eye with aurovisc may cause increased intraocular
pressure, glaucoma or other associated ocular damage. The following precautions are
recommended during surgical procedures.
- Do not overfill the eye chamber with AUROVISC
- AUROVISC should be removed from anterior chamber at the end of surgery. Remove as
much AUROVISC by irrigation and / or aspiration at the end of surgery while of not
jeopardizing the integrity of corneal endothelial cells.
- Carefully monitor intraocular pressure especially during the immediate post operative
period. Transient increased IOP may occur following surgery because of pre existing
glaucoma or due to surgery itself. If the post operative IOP increases above expected
values, treat with appropriate therapy.
- Installation of AUROVISC should be done so as to avoid trapping of air bubbles behind
hydroxypropyl methylcellulose solution.
- Avoid reuse of cannula.
- Although not reported to date, the concurrent presence of medication in the chamber
or associated ocular structures may interact with Aurovisc to cause clouding. Physicians
should consider this potential if such a phenomenon is observed.
CONTRAINDICATIONS
It is contraindicated in patients with known history of hypersensitivity to its ingredients.
SUPPLY
3 ml, 5 ml vials and 2 ml pre-filled glass syringes in double pouch packing.
|
